|
|
Volumn 5, Issue 1, 2004, Pages 40-49
|
|
First International Workshop on HIV-1 persistence during therapy
a
b,c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR;
AMPRENAVIR;
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
CHEMOKINE RECEPTOR CCR5;
GLYCOPROTEIN GP 120;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
HYDROXYUREA;
IMMUNOTOXIN;
INDINAVIR;
INTERLEUKIN 2;
LAMIVUDINE;
LOPINAVIR;
MYCOPHENOLIC ACID;
NEF PROTEIN;
OKT 3;
RAPAMYCIN;
RECEPTOR ANTIBODY;
RECEPTOR BLOCKING AGENT;
STAVUDINE;
VIF PROTEIN;
VIRUS DNA;
VIRUS RNA;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADOPTIVE IMMUNOTHERAPY;
ARTICLE;
DRUG BLOOD LEVEL;
DRUG MECHANISM;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION CONTROL;
MACROPHAGE;
MUTATIONAL ANALYSIS;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PERSISTENT VIRUS INFECTION;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
T LYMPHOCYTE;
VIREMIA;
VIROLOGY;
VIRUS GENOME;
VIRUS IMMUNITY;
VIRUS LOAD;
VIRUS PATHOGENESIS;
VIRUS TRANSMISSION;
WORKSHOP;
ANTI-RETROVIRAL AGENTS;
ANTIGENS, CD4;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
DNA, COMPLEMENTARY;
DNA, VIRAL;
GENES, PX;
HIV INFECTIONS;
HIV-1;
HUMANS;
RNA, MESSENGER;
VIREMIA;
|
|
EID: 1642341343
PISSN: 15284336
EISSN: None
Source Type: Journal
DOI: 10.1310/DXTA-G1FU-2KRF-EX3K Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
